Non-specific proteins and surfaces

Non-specific proteins and surfaces refer to the broad category of biological and physical entities that interact with pharmaceutical agents through non-selective forces rather than specific molecular recognition. In a physiological context, this primarily involves abundant plasma proteins such as human serum albumin and alpha-1-acid glycoprotein, which sequester drugs and influence their pharmacokinetics (NIH, StatPearls: Drug Protein Binding). In laboratory environments, non-specific binding occurs when compounds adsorb to the plastic or glass surfaces of assay plates and tubing, often leading to underestimations of drug potency (Gervais et al., 2003, Advanced Drug Delivery Reviews). While not a therapeutic target, these interactions are critical to understand because only the unbound or free fraction of a drug is typically capable of exerting a pharmacological effect at its intended site of action. High non-specific binding can lead to a low volume of distribution and slow clearance, but it also poses risks for drug-drug interactions if one agent displaces another from these sites (Smith et al., 2010, Clinical Pharmacokinetics). Consequently, managing non-specific interactions is a major focus in drug design to ensure predictable safety and efficacy profiles.

Other names

Non-specific binding sitesNSBPlasma protein binding sitesSurface adsorptionOff-target binding

Non-selective hydrophobic, electrostatic, and Van der Waals interactions